NL
TEVA icon

NVWM LLC’s Teva Pharmaceuticals TEVA Stock Holding History

NVWM LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$753 – 477
2023
Q2 		$753 Buy
+100
New +$811 ﹤0.01% 428
2022
Q1 		– Sell
-50
Closed – – 610
2021
Q4 		$0 Hold
50
– – ﹤0.01% 539
2021
Q3 		$0 Hold
50
– – ﹤0.01% 523
2021
Q2 		$0 Hold
50
– – ﹤0.01% 462
2021
Q1 		$1K Buy
+50
New +$573 ﹤0.01% 403
2019
Q4 		– Sell
-100
Closed -$1K – 356
2019
Q3 		$1K Hold
100
– – ﹤0.01% 348
2019
Q2 		$1K Hold
100
– – ﹤0.01% 361
2019
Q1 		$2K Hold
100
– – ﹤0.01% 316
2018
Q4 		$2K Buy
+100
New +$2.05K ﹤0.01% 329

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

NVWM LLC's TEVA Position: Q3 2023 in Review

NVWM LLC sold out of Teva Pharmaceuticals (TEVA) in Q3 2023, closing a stake of 100 shares — an estimated $753 sold.

NVWM LLC first reported a position in TEVA in Q4 2018 and held it in 9 quarters. The position peaked at $2K in Q1 2019. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • NVWM LLC reported no remaining Teva Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • NVWM LLC sold 100 Teva Pharmaceuticals shares in Q3 2023, an estimated $753.
  • NVWM LLC first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 9 quarters.
  • NVWM LLC's Teva Pharmaceuticals position peaked at $2K in Q1 2019.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on NVWM LLC's 13F filing for Q3 2023, filed 30 Oct 2023.